Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has shared an update.
Charmacy Pharmaceutical Co., Ltd. reported its annual financial results for the year ending December 31, 2024, showing a slight increase in operating revenue to RMB4,435.46 million, up 0.72% from the previous year. The company’s net profit also rose by 3.78% to RMB53.28 million. The board has recommended a final dividend of RMB0.45 per share. These results indicate a stable financial performance, reflecting the company’s steady position in the pharmaceutical market.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company incorporated in the People’s Republic of China, operating within the pharmaceutical industry. The company is primarily focused on the distribution and sale of pharmaceutical products.
YTD Price Performance: -20.61%
Average Trading Volume: 4,888
Technical Sentiment Signal: Buy
Current Market Cap: HK$840.2M
For a thorough assessment of 2289 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue